Morocco and Saudi Arabia formalized a new strategic alliance in the field of health and social protection, through the signing of a memorandum of understanding on Friday, August 16 in Rabat.
This agreement, initialed by Khalid Aït Taleb, Moroccan Minister of Health and Social Protection, and his Saudi counterpart Fahad Bin Abdurrahman Al-Jalajel, marks a key step in strengthening bilateral cooperation to address pandemics and health crises.
Strengthening health capacities
The MoU aims to improve the quality of healthcare, enhance patient safety, and effectively combat pandemics and epidemics. This partnership includes measures for the early detection of epidemics and the implementation of necessary actions to control them. It also focuses on strengthening public health, preventive medicine, and curative medicine, while integrating advances in digital health and virtual medicine.
Expanded cooperation in blood transfusion services
An important dimension of this agreement is the exploration of possibilities for cooperation in the field of blood transfusion services.
The two countries intend to collaborate to ensure a sufficient and safe supply of blood, thus meeting the growing needs of their respective populations.
Exchanges of expertise and scientific research
The memorandum stipulates that the terms of this cooperation will be implemented through various means, including the exchange of information and expertise, the organization of visits of experts and specialists, as well as the organization of conferences and seminars.
Health training, the encouragement of scientific research, and the exchange of information in medicine and telemedicine are also among the priorities.
Presentation of Moroccan reforms to the Saudi delegation
During this meeting, the Saudi delegation was able to discover the various projects undertaken by Morocco to reform its national health system. This includes in particular initiatives in terms of social protection, universal health coverage, as well as advances in the pharmaceutical industry and vaccine production.
